This competitive renewal proposal is to develop pulse saturation-recovery
(SR) electron paramagnetic resonance (EPR) for application to spin
labels in a context of site directed spin labeling (SDSL). The applicant's
laboratory has recently made a breakthrough in SR detection based
on a novel digital sub-sampling strategy, which has been termed time locked
sub-sampling, and a new pulse spectrometer is under construction. Thorough
engineering evaluation and design optimization including signal processing
software are proposed for the next funding period. Feasibility for a new X-band
bimodal loop gap sample resonator has also been demonstrated and further
innovation is proposed. Engineering-based development follows naturally from
the work of the previous funding period. SR can measure the rate of bimolecular
collisions of spin labels with oxygen, and is a primary methodology for
studying oxygen transport. Spin label oximetry is an important tool in
identification of structural motifs such as alpha-helices or beta-sheets in
proteins through SDSL methods. Three model systems are used here in each of
three application-based specific aims. The model systems, in order of
increasing biological relevance, are maleimide spin label in super-cooled
sec-butylbenzene, hemoglobin labeled at beta93 in glycerol-water mixtures, and
the ferric enterobactin receptor, Fep-A. The SR method is validated and
compared with more conventional methodology. A novel SR method to separate
overlapped spectra, termed discrimination by oxygen transport, is used to
characterize multiple motional components of FepA. SR apparatus acquires
intense free induction decay (FID) signals that are normally suppressed.
Instead, this investigator proposes to use FID signals to measure site-to-site
distances in double-labeled FepA. Frequency swept pulse electron-electron
double resonance is introduced to characterize slow restricted angle motions in
Fep-A in a situation where overall motion of the protein is negligible. The
detection method, the bimodal resonator, use of FID signals for distance
determination, use of SR to separate overlapped spectra, and measurement for
the first time of restricted-angle motions are thought to be highly innovative.
SDSL is a new and rapidly expanding methodology in structural biology. Addition
of saturation recovery to SDSL methodology will, we hypothesize, revolutionize
the field. The proposal lies at the foundation of modern biomedical research:
development of tools that enhance one's ability to determine protein structure,
dynamics and function. The investigator asserts that only on such a foundation
can a rational approach to improved human health be based.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
biomedical equipment developmentcomputer program /softwarecomputer system design /evaluationcopperelectron spin resonance spectroscopymetal complexmetalloproteinsmethod developmentoxygen transport
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
937639060
UEI
E8VWJXMMUQ67
Project Start Date
01-July-1979
Project End Date
30-June-2004
Budget Start Date
01-July-2003
Budget End Date
30-June-2004
Project Funding Information for 2003
Total Funding
$322,371
Direct Costs
$221,500
Indirect Costs
$100,871
Year
Funding IC
FY Total Cost by IC
2003
National Institute of Biomedical Imaging and Bioengineering
$322,371
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 8R01EB002052-25
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 8R01EB002052-25
Patents
No Patents information available for 8R01EB002052-25
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 8R01EB002052-25
Clinical Studies
No Clinical Studies information available for 8R01EB002052-25
News and More
Related News Releases
No news release information available for 8R01EB002052-25
History
No Historical information available for 8R01EB002052-25
Similar Projects
No Similar Projects information available for 8R01EB002052-25